| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
10,517 |
8,810 |
$65K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,405 |
5,671 |
$58K |
| 80061 |
Lipid panel |
7,452 |
6,392 |
$54K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,546 |
3,047 |
$50K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
938 |
764 |
$39K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,437 |
6,907 |
$37K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
597 |
456 |
$26K |
| 36415 |
Collection of venous blood by venipuncture |
8,706 |
6,959 |
$25K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
840 |
793 |
$21K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
836 |
789 |
$21K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
587 |
496 |
$20K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,093 |
3,483 |
$19K |
| 81170 |
|
81 |
48 |
$16K |
| 82607 |
|
1,747 |
1,491 |
$15K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
666 |
597 |
$14K |
| 80050 |
General health panel |
890 |
769 |
$13K |
| 84439 |
|
2,362 |
2,004 |
$12K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
821 |
740 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
186 |
52 |
$11K |
| 85027 |
|
2,856 |
2,486 |
$11K |
| 82746 |
|
1,256 |
1,066 |
$11K |
| 86803 |
|
1,142 |
964 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
282 |
264 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,570 |
1,438 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,644 |
1,367 |
$7K |
| 84153 |
|
731 |
646 |
$7K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
406 |
384 |
$7K |
| 81301 |
|
39 |
12 |
$6K |
| 82728 |
|
733 |
654 |
$5K |
| 86140 |
|
1,315 |
931 |
$4K |
| 87088 |
|
824 |
741 |
$4K |
| 84403 |
|
232 |
201 |
$4K |
| 88142 |
|
309 |
295 |
$4K |
| 83550 |
|
766 |
657 |
$3K |
| 87070 |
|
579 |
535 |
$3K |
| 81310 |
|
23 |
14 |
$3K |
| 81306 |
|
20 |
12 |
$3K |
| 87077 |
|
565 |
522 |
$3K |
| 83735 |
|
829 |
678 |
$3K |
| 83540 |
|
906 |
783 |
$3K |
| 86703 |
|
334 |
266 |
$3K |
| 81206 |
|
24 |
12 |
$3K |
| 82570 |
|
967 |
868 |
$3K |
| 86038 |
|
387 |
331 |
$3K |
| 87081 |
|
608 |
557 |
$3K |
| 81001 |
|
1,207 |
1,060 |
$2K |
| 82043 |
|
619 |
580 |
$2K |
| 81187 |
|
25 |
13 |
$2K |
| 81241 |
|
46 |
23 |
$2K |
| 87340 |
|
297 |
235 |
$2K |
| 86850 |
|
273 |
233 |
$2K |
| 86039 |
|
237 |
218 |
$2K |
| 81109 |
|
23 |
15 |
$2K |
| 80076 |
|
308 |
225 |
$2K |
| 86592 |
|
559 |
488 |
$1K |
| 84550 |
|
596 |
503 |
$1K |
| 85652 |
|
884 |
661 |
$1K |
| 87186 |
|
255 |
214 |
$1K |
| 82044 |
|
334 |
282 |
$1K |
| 83001 |
|
114 |
103 |
$1K |
| 86787 |
|
152 |
112 |
$1K |
| 81240 |
|
26 |
16 |
$1K |
| 85651 |
|
428 |
298 |
$1K |
| 82248 |
|
337 |
299 |
$1K |
| 86431 |
|
260 |
224 |
$979.00 |
| 80159 |
|
61 |
40 |
$904.08 |
| 84270 |
|
62 |
50 |
$890.24 |
| 86762 |
|
93 |
79 |
$861.08 |
| 83880 |
|
51 |
45 |
$773.00 |
| 80198 |
|
102 |
56 |
$751.83 |
| 80176 |
|
59 |
37 |
$676.02 |
| 84436 |
|
204 |
164 |
$666.93 |
| 81003 |
|
465 |
400 |
$653.69 |
| 80175 |
|
61 |
38 |
$630.87 |
| 80162 |
|
74 |
44 |
$539.60 |
| 80299 |
|
29 |
17 |
$531.74 |
| 84146 |
|
49 |
42 |
$529.55 |
| 80185 |
|
54 |
28 |
$529.18 |
| 86317 |
|
53 |
45 |
$491.43 |
| 80074 |
|
41 |
40 |
$487.63 |
| 84481 |
|
42 |
37 |
$481.70 |
| 80051 |
|
121 |
68 |
$472.92 |
| 80180 |
|
34 |
17 |
$455.04 |
| 86900 |
|
232 |
197 |
$451.71 |
| 86901 |
|
232 |
197 |
$448.73 |
| 86403 |
|
35 |
33 |
$326.41 |
| 84100 |
|
145 |
103 |
$317.97 |
| 80178 |
|
76 |
45 |
$301.77 |
| 80184 |
|
25 |
16 |
$301.25 |
| 80177 |
|
35 |
20 |
$297.29 |
| 86200 |
|
34 |
27 |
$295.80 |
| 80145 |
|
54 |
31 |
$293.61 |
| 85610 |
|
195 |
124 |
$273.45 |
| 80164 |
|
52 |
45 |
$256.69 |
| 83690 |
|
65 |
58 |
$255.82 |
| 87210 |
|
61 |
52 |
$226.91 |
| 80192 |
|
24 |
13 |
$211.04 |
| 80197 |
|
28 |
16 |
$183.42 |
| 82105 |
|
13 |
13 |
$171.73 |
| 87205 |
|
67 |
59 |
$171.12 |
| 87147 |
|
41 |
39 |
$159.12 |
| 83970 |
|
12 |
12 |
$130.04 |
| 86706 |
|
25 |
17 |
$109.98 |
| 84480 |
|
15 |
12 |
$100.53 |
| 84156 |
|
59 |
51 |
$99.34 |
| 81005 |
|
52 |
32 |
$78.58 |
| 87040 |
|
14 |
13 |
$52.82 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
230 |
209 |
$38.64 |